| Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the … RG Miller, CE Jackson, EJ Kasarskis, JD England, D Forshew, ... Neurology 73 (15), 1218-1226, 2009 | 890 | 2009 |
| Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an … RG Miller, CE Jackson, EJ Kasarskis, JD England, D Forshew, ... Neurology 73 (15), 1227-1233, 2009 | 712 | 2009 |
| Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide L Ganzini, WS Johnston, BH McFarland, SW Tolle, MA Lee New England Journal of Medicine 339 (14), 967-973, 1998 | 451 | 1998 |
| Correlates of suffering in amyotrophic lateral sclerosis L Ganzini, WS Johnston, WF Hoffman Neurology 52 (7), 1434-1434, 1999 | 321 | 1999 |
| The final month of life in patients with ALS L Ganzini, WS Johnston, MJ Silveira Neurology 59 (3), 428-431, 2002 | 175 | 2002 |
| Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and Washington L Ganzini, MJ Silveira, WS Johnston Journal of pain and symptom management 24 (3), 312-317, 2002 | 162 | 2002 |
| Late‐onset mitochondrial myopathy W Johnston, G Karpati, S Carpenter, D Arnold, EA Shoubridge Annals of Neurology: Official Journal of the American Neurological …, 1995 | 161 | 1995 |
| Dignity and distress towards the end of life across four non-cancer populations HM Chochinov, W Johnston, SE McClement, TF Hack, B Dufault, M Enns, ... PloS one 11 (1), e0147607, 2016 | 113 | 2016 |
| Promoting excellence in end‐of‐life care in ALS H Mitsumoto, M Bromberg, W Johnston, R Tandan, I Byock, M Lyon, ... Amyotrophic Lateral Sclerosis 6 (3), 145-154, 2005 | 107 | 2005 |
| Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy S Kalra, CC Hanstock, WRW Martin, PS Allen, WS Johnston Archives of neurology 63 (8), 1144-1148, 2006 | 97 | 2006 |
| Rituximab in refractory myasthenia gravis: a prospective, open‐label study with long‐term follow‐up D Anderson, C Phan, WS Johnston, ZA Siddiqi Annals of clinical and translational neurology 3 (7), 552-555, 2016 | 85 | 2016 |
| Palliative care in amyotrophic lateral sclerosis: from diagnosis to bereavement D Oliver, GD Borasio, W Johnston OUP Oxford, 2014 | 77 | 2014 |
| Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary … RG Miller, CE Jackson, EJ Kasarskis, JD England, D Forshew, ... Neurology 73 (15), 1227-1233, 2009 | 74 | 2009 |
| Symptom Factor Analysis, Clinical Findings, and Functional Status in a Population-Based Case Control Study of Gulf WarUnexplained Illness DN Bourdette, LA McCauley, A Barkhuizen, W Johnston, M Wynn, ... Journal of Occupational and Environmental Medicine 43 (12), 1026-1040, 2001 | 73 | 2001 |
| Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis RA Osborne, R Sekhon, W Johnston, S Kalra Journal of the neurological sciences 336 (1-2), 191-196, 2014 | 67 | 2014 |
| Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis T Pyra, B Hui, C Hanstock, L Concha, JCT Wong, C Beaulieu, W Johnston, ... Amyotrophic Lateral Sclerosis 11 (1-2), 157-165, 2010 | 64 | 2010 |
| Canadian best practice recommendations for the management of amyotrophic lateral sclerosis C Shoesmith, A Abrahao, T Benstead, M Chum, N Dupre, A Izenberg, ... CMAJ 192 (46), E1453-E1468, 2020 | 63 | 2020 |
| Spatial profiling of the corticospinal tract in amyotrophic lateral sclerosis using diffusion tensor imaging JCT Wong, L Concha, C Beaulieu, W Johnston, PS Allen, S Kalra Journal of Neuroimaging 17 (3), 234-240, 2007 | 58 | 2007 |
| A controlled trial of recombinant methionyl human BDNF in ALS EJ Kasarskis, JM Shefner, R Miller, RA Smith, J Licht, H Mitsumoto, ... Neurology 52 (7), 1427-1433, 1999 | 55 | 1999 |
| A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS JM Shefner, JA Andrews, A Genge, C Jackson, N Lechtzin, TM Miller, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22 (3-4), 287-299, 2021 | 50 | 2021 |
Sanjay KalraUniversity of AlbertaBestätigte E-Mail-Adresse bei ualberta.ca
